Droperidol on Prevention of Cannabis Hyperemesis Syndrome
Public ClinicalTrials.gov record NCT05244460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Droperidol on Prevention of Emesis From Cannabinoid Hyperemesis Syndrome
Study identification
- NCT ID
- NCT05244460
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Mercy Health Ohio
- Other
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Interventions
- Diphenhydramine Drug
- Droperidol Injectable Product Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2021
- Primary completion
- Jan 30, 2023
- Completion
- Jan 30, 2023
- Last update posted
- Jan 19, 2023
2021 – 2023
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mercy Health - Austintown | Austintown | Ohio | 44515 | Recruiting |
| St Elizabeth Boardman Hospital | Boardman | Ohio | 44512 | Recruiting |
| St. Joseph-Warren Hospital | Warren | Ohio | 44484 | Recruiting |
| St Elizabeth Youngstown Hospital | Youngstown | Ohio | 44501 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05244460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05244460 live on ClinicalTrials.gov.